Palabras clave
Anestesia
Fisiología
Farmacología
Complicaciones de la TEC
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Abordar los principales cuidados anestésicos para los pacientes sometidos a TEC. Revisión de la literatura: Partiendo del supuesto de que los pacientes esquizofrénicos que sufrían convulsiones mostraban mejoría de los síntomas psicóticos, y de la observación post mortem del aumento (más allá de las expectativas) de la concentración de células gliales en pacientes epilépticos y su reducción en pacientes con esquizofrenia, se postuló que las convulsiones tendrían efectos terapéuticos. Se desarrollaron varios métodos para inducir convulsiones, inicialmente utilizando medicamentos, que producían resultados terapéuticos variables con numerosos efectos secundarios. Más tarde, en la década de 1930, con el uso de la electricidad, se obtuvieron resultados más precisos con mayor seguridad para el paciente. Consideraciones finales: La llegada de la anestesia hizo que el procedimiento fuera aún más seguro, más humano, efectivo y mejor tolerado. Más recientemente, las indicaciones para la realización de TEC se han ampliado, haciendo imperativo que los profesionales involucrados tengan conocimientos sobre las respuestas fisiológicas, interacciones farmacológicas, posibles complicaciones y contraindicaciones de la TEC.
Referencias
ABOU-SALEH M, et al. Eletroconvulsoterapia: critérios e recomendações da Associação Mundial de Psiquiatria. Revista de Psiquiatria Clínica, São Paulo, 2004; 31(5): 263-268.
AKHTAR SM, et al. Beyond the surface: analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy—A systematic review and meta-analysis of seizure duration outcomes. Frontiers in Neurology, 2023; 14: 1251882.
AOKI N, et al. Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials. Journal of psychiatric research, 2021; 141: 16-25.
CASTELLI I, et al. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesthesia & Analgesia,1995; 80(3): 557-561.
CHAWLA N. Anesthesia for electroconvulsive therapy. Anesthesiology Clinics, 2020; 38(1): 183-195.
DAI X, et al. Anesthetic Influence on Electroconvulsive Therapy: A Comprehensive Review. Neuropsychiatric Disease and Treatment, 2024; 1491-1502.
DEINER S, et al. Electroconvulsive therapy and anesthesia. International anesthesiology clinics, 2009; 47(2): 81-92.
DELVA NJ, et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. The journal of ECT, 2020; 16(4): 361-369.
DING Z, et al. Anesthesia for electroconvulsive therapy. Anesthesia & Analgesia,2002; 94 (5): 1351-1364.
FOLK JW, et al. Anesthesia for electroconvulsive therapy: a review. J ECT 2000; 16: 157–70.
FU W, et al. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. Journal of clinical anesthesia,1997; 9(8): 653-657.
GAINES GY e REES DI. Electroconvulsive therapy and anesthetic considerations. Anesthesia & Analgesia,1986; 65(12): 1345-1356.
GERLACH AT, et al. Dexmedetomidine: an updated review. Annals of Pharmacotherapy,2007; 41(2): 245-254.
GUREL SC, et al. The superiority of ketofol and etomidate against propofol or thiopental anesthesia for ECT. Asian Journal of Psychiatry, 2022; 72: 103090.
HERMIDA AP, et al. The cardiovascular side effects of electroconvulsive therapy and their management. The Journal of ECT,2022; 38(1): 2-9.
JOUNG KW, et al. Anesthetic care for electroconvulsive therapy. Anesthesia and Pain Medicine, 2022; 17(2): 145-156.
KELLNER CH, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Archives of general psychiatry,2006; 63(12): 1337-1344.
KHAN A, et al. Electroconvulsive therapy. Psychiatric Clinics of North America, 1993; 16 (3): 497-513.
LAVA-PARMELE S, et al. The historical struggles of modified electroconvulsive therapy: how anesthesia came to the rescue. Journal of anesthesia history, 2021; 7(2): 17-25.
LEE K, et al. A narrative overview of current anesthetic drugs in electroconvulsive therapy. Life, 2021; 11(9): 981.
LOPEZ-GOMEZ D, et al. Myocardial infarction after electroconvulsive therapy. Revista española de cardiología,1999; 52(7): 536-536.
MAIXNER D, et al. Electroconvulsive therapy is an essential procedure. American Journal of Psychiatry,2021; 178(5): 381-382.
MAYUR PM, et al. Acute post-ECT cardiovascular response: a comparison of threshold right unilateral and bilateral ECT. The Journal of ECT, 1998; 14(2): 94-98.
NG C, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. The Journal of ECT, 2000; 16 (4): 370-379.
NIKOLIN S, et al. Comparison of site localization techniques for brain stimulation. The Journal of ECT, 2019; 35(2): 127-132.
PRUDIC J, et al. Effectiveness of electroconvulsive therapy in community settings. Biological psychiatry, 2004; 55(3): 301-312.
RIKHER KV, et al. Cortical blindness after electroconvulsive therapy. The Journal of the American Board of Family Practice, 1997; 10(2): 141-143.
SAITO S, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Canadian Journal of Anesthesia, 2000; 47: 767-774.
SAITO S, et al. Regional cerebral oxygen saturation during electroconvulsive therapy: monitoring by near-infrared spectrophotometry. Anesthesia & Analgesia, 1996; 83(4): 726-730.
SEGMAN RH, et al. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology, 1995; 119: 440-448.
SEMKOVSKA M, et al. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological psychiatry, 2010; 68 (6): 568-577.
SOEHLE M, et al. Challenges and pitfalls in anesthesia for electroconvulsive therapy. Best Practice & Research Clinical Anaesthesiology, 2021; 35 (2): 181-189.
SURVE RM, et al. Electroconvulsive therapy services during COVID-19 pandemic. Asian Journal of Psychiatry, 2021; 59: 102653.
SWARTZ CM. Physiological response to ECT stimulus dose. Psychiatry research, 2000; 97(2-3): 229-235.
TAJABADI N, et al. The Effects of Remifentanil, Dexmedetomidine, and Metoral as Adjuncts to Thiopental on Hemodynamic Status After Electroconvulsive Therapy in Patients with Major Depressive Disorder: A Randomized Controlled Clinical Trial. Anesthesiology and Pain Medicine, 2023; 13(5).
TAKEKITA Y, et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. European archives of psychiatry and clinical neuroscience, 2016; 266: 703-717.
WEINER RD. American Psychiatric Association committee on electroconvulsive therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging, 2001; 2: 1040-41.
WEINGER MB, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol. Anesthesia & Analgesia, 1991; 73 (5): 563-569.
WEISBERG LA, et al. Intracerebral hemorrhage following electroconvulsive therapy. Neurology, 1991.
ZACHRISSON OG, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry research, 2000; 96 (2): 157-165.